Home » Newsletters » BioWorld Science

BioWorld Science

March 20, 2014

View Archived Issues

New approach to melanoma treatment: TR3-mediated autophagic cell death

Discovery of potent oral p53-Mdm2 inhibitors

Peanut allergy model created via bone marrow transplant

New study investigates third-generation CAR T-cell therapy with incorporated safety switch

Researchers at Merck & Co. design novel AMPK activators for diabetes

Array BioPharma and Genentech present new ERK inhibitors

Merck & Co. presents novel SYK inhibitors for the treatment of rheumatoid arthritis

Enrollment under way in Alcobra's phase III trial of MDX for adult ADHD

Compound library partnership established between Astellas and Daiichi Sankyo

Bristol-Myers Squibb presents data for BMS-903452

Sanofi Pasteur and SK Chemical collaborate on pneumococcal conjugate vaccine

biOasis Technologies, MedImmune sign agreement for second-generation brain delivery platform

TRPA1 antagonists described for the potential treatment of familial episodic pain syndrome

Chinese group presents novel agents for HIV and HBV infection

Researchers at the Virginia Commonwealth University disclose novel conjugates for cancer

Portola Pharmaceuticals begins phase III study of andexanet alfa

First patient enrolled in phase I study of AG-120

Dartmouth and Aeras to study new tuberculosis vaccine, DAR-901

Novel biomarker for colon cancer

Isis Pharmaceuticals begins phase I study of ISIS-ANGPTL3Rx to treat hyperlipidemia

AdvanDx submits application to FDA seeking approval of rapid MRSA test

Phase Ia results for HMS-5552 lead to initiation of phase Ib study

FDA approves Impavido for leishmaniasis

Emmaus Life Sciences reports topline data from phase III sickle cell disease trial

Merck & Co. initiates North American phase III development of SLIT tablet

Navidea Biopharmaceuticals discusses Lymphoseek MAA with EMA committee

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...